These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29694960)

  • 1. Kynurenine Pathway in Autism Spectrum Disorders in Children.
    Bryn V; Verkerk R; Skjeldal OH; Saugstad OD; Ormstad H
    Neuropsychobiology; 2017; 76(2):82-88. PubMed ID: 29694960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Tryptophan, Tryptophan Catabolites and Brain-derived Neurotrophic Factor in Subgroups of Youngsters with Autism Spectrum Disorders.
    Ormstad H; Bryn V; Verkerk R; Skjeldal OH; Halvorsen B; Saugstad OD; Isaksen J; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(8):626-639. PubMed ID: 30033880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine, Kynurenic Acid, Quinolinic Acid and Interleukin-6 Levels in the Serum of Patients with Autism Spectrum Disorder.
    Yildirim V; Simsek S; Cetin I; Dokuyucu R
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003955
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
    Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
    Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
    Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
    Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis.
    Almulla AF; Thipakorn Y; Tunvirachaisakul C; Maes M
    Autism Res; 2023 Dec; 16(12):2302-2315. PubMed ID: 37909397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine pathway and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives.
    Carpita B; Nardi B; Palego L; Cremone IM; Massimetti G; Carmassi C; Betti L; Giannaccini G; Dell'Osso L
    CNS Spectr; 2023 Jun; 28(3):374-385. PubMed ID: 35634735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine Profile in Autism Spectrum Disorders in Children.
    Bryn V; Aass HC; Skjeldal OH; Isaksen J; Saugstad OD; Ormstad H
    J Mol Neurosci; 2017 Jan; 61(1):1-7. PubMed ID: 27730473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine and its metabolites in Alzheimer's disease patients.
    Gulaj E; Pawlak K; Bien B; Pawlak D
    Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
    Gevi F; Zolla L; Gabriele S; Persico AM
    Mol Autism; 2016; 7():47. PubMed ID: 27904735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered kynurenine pathway metabolite levels in toddlers and preschool children with autism spectrum disorder.
    Bilgiç A; Abuşoğlu S; Sadıç Çelikkol Ç; Oflaz MB; Akça ÖF; Sivrikaya A; Baysal T; Ünlü A
    Int J Neurosci; 2022 Aug; 132(8):826-834. PubMed ID: 33086922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
    Cihan M; Doğan Ö; Ceran Serdar C; Altunçekiç Yıldırım A; Kurt C; Serdar MA
    J Clin Lab Anal; 2022 Mar; 36(3):e24257. PubMed ID: 35092710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.